Risedronate sodium
Cat. No.：YN481779
CAS No. ：115436-72-1
规格
价格(RMB)
库存
| 产品名称: | Risedronate sodium |
| CAS No.: | 115436-72-1 |
| Chemical Name: | P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-phosphonic acid, monosodium salt |
| Synonyms: | 利塞膦酸钠; Risedronic Acid Sodium |
| 分子量: | 305.09 |
| 分子式: | C₇H₁₀NNaO₇P₂ |
| SMILES: | OC(P(O)(O)=O)(P(O)([O-])=O)CC1=CN=CC=C1.[Na+] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Risedronate钠是双磷酸盐，能抑制破骨细胞介导的骨吸收。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Nuti, R.Updates on mechanism of action and clinical efficacy of risedronate in osteoporosisClin. Cases Miner. Bone Metab.11(3),208-214(2014)
Lems, W.F., and den Heijer, M.Established and forthcoming drugs for the treatment of osteoporosisNeth. J. Med.71(4),188-193(2013)
Jordao, F.M., Saito, A.Y., Miguel, D.C., et al.In vitro and in vivo antiplasmodial activities of risedronate and its interference with protein prenylation in Plasmodium falciparumAntimicrob. Agents Chemother.55(5),2026-2031(2011)
Pereira, R.M.R., de Carvalho, J.F., Paula, A.P., et al.Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosisRev. Bras. Reumatol.52(4),580-593(2012)
